Paper39296014
Long noncoding RNA ZFAS1 exerts a suppressive impact on ferroptosis by modulating the miR-150/AIFM2 axis in hepatocellular carcinoma cells.
Wang G and 3 others. Heliyon, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Long noncoding RNA ZFAS1 exerts a suppressive impact on ferroptosis by modulating the miR-150/AIFM2 axis in hepatocellular carcinoma cells. Papers, record 39296014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39296014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long noncoding RNA ZFAS1 exerts a suppressive impact on ferroptosis by modulating the miR-150/AIFM2 axis in hepatocellular carcinoma cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32547074 | The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32547074 | PubMed |
| 2 | 25549355 | RETRACTED: miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14. | PLoS One | 2014 | https://conductscience.org/library/papers/25549355 | PubMed |
| 3 | 28975833 | The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer. | Cancer Control | 2017 | https://conductscience.org/library/papers/28975833 | PubMed |
| 4 | 30288832 | ZFAS1: A novel vital oncogenic lncRNA in multiple human cancers. | Cell Prolif | 2019 | https://conductscience.org/library/papers/30288832 | PubMed |
| 5 | 30186041 | ZFAS1: a novel tumor-related long non-coding RNA. | Cancer Cell Int | 2018 | https://conductscience.org/library/papers/30186041 | PubMed |
| 6 | 35216678 | CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35216678 | PubMed |
| 7 | 30889053 | Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma. | Melanoma Res | 2019 | https://conductscience.org/library/papers/30889053 | PubMed |
| 8 | 36923440 | Roles of lncRNAs in childhood cancer: Current landscape and future perspectives. | Front Oncol | 2023 | https://conductscience.org/library/papers/36923440 | PubMed |
| 9 | 33762576 | Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway. | Int J Oral Sci | 2021 | https://conductscience.org/library/papers/33762576 | PubMed |
| 10 | 37735151 | AIFM2 promotes hepatocellular carcinoma metastasis by enhancing mitochondrial biogenesis through activation of SIRT1/PGC-1α signaling. | Oncogenesis | 2023 | https://conductscience.org/library/papers/37735151 | PubMed |
| 11 | 36584761 | Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. | Prog Biophys Mol Biol | 2023 | https://conductscience.org/library/papers/36584761 | PubMed |
| 12 | 32847098 | Diagnostic and Prognostic Significance of MiR-150 in Colorectal Cancer: A Systematic Review and Meta-Analysis. | J Pers Med | 2020 | https://conductscience.org/library/papers/32847098 | PubMed |
| 13 | 35718122 | WITHDRAWN: miR-150-5p inhibits nasopharyngeal cancer genesis by suppressing PYCR1. | Am J Med Sci | 2022 | https://conductscience.org/library/papers/35718122 | PubMed |
| 14 | 26403645 | Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. | Hepatology | 2016 | https://conductscience.org/library/papers/26403645 | PubMed |
| 15 | 26215970 | microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. | Diagn Pathol | 2015 | https://conductscience.org/library/papers/26215970 | PubMed |
| 16 | 31634899 | FSP1 is a glutathione-independent ferroptosis suppressor. | Nature | 2019 | https://conductscience.org/library/papers/31634899 | PubMed |
| 17 | 30996051 | Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma. | Clin Chem | 2019 | https://conductscience.org/library/papers/30996051 | PubMed |
| 18 | 35418578 | Targeting non-coding RNAs to overcome cancer therapy resistance. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35418578 | PubMed |
| 19 | 34609043 | Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34609043 | PubMed |
| 20 | 35112985 | Long non-coding RNA ZFAS1 regulates cell proliferation and invasion in cervical cancer via the miR-190a-3p/KLF6 axis. | Bioengineered | 2022 | https://conductscience.org/library/papers/35112985 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41585137 | Apoptosis-inducing factor mitochondria-associated 2 (AIFM2) promotes tumor progression and predicts poor prognosis in oral squamous cell carcinoma. | J Dent Sci | 2026 | https://conductscience.org/library/papers/41585137 | PubMed |
| 41450817 | LncRNA ZFAS1 in hepatocellular carcinoma: A systematic review of molecular mechanisms and clinical translation. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/41450817 | PubMed |
| 40789840 | Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40789840 | PubMed |
| 40234311 | Key genes and processes affected by atorvastatin treatment in mouse diaphragm muscle. | Arch Toxicol | 2025 | https://conductscience.org/library/papers/40234311 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AIFM2 | 84883 | PubTator's text mining | https://conductscience.org/library/genes/84883 | NCBI Gene |
| MIR150 | 406942 | PubTator's text mining | https://conductscience.org/library/genes/406942 | NCBI Gene |
| ZFAS1 | 441951 | PubTator's text mining | https://conductscience.org/library/genes/441951 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39296014
GET https://conductscience.org/api/papers/v1/39296014/references?page=2